0116

Welcome to the January issue. Our upfront topics range from a cross-country cancer cost comparison, to details of the French cancer trial tragedy. Our feature speculates on the future of the Biopharmaceutical Industry – discussing the role of Immuno-oncology, gene editing and other emerging therapeutic techniques. In best practice, Lisa Allen discusses the approaching deadline for the European Union’s REACH regulation, in NextGen, Miguel Forte discusses the role of vendors and manufacturing organizations to cell therapies, and we Sit Down With Diane Paskiet of West Pharmaceutical Services.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Discovery & Development Clinical Trials

A Brave New Year

02/09/2016 | Stephanie Vine

How do we move on from a sombre start to 2016?

Business & Regulation Business Practice

Cross-Country Cancer Cost Comparison

02/09/2016

Oncology medication prices can vary significantly between countries – but by how much and why?

Discovery & Development Drug Delivery

Bio-Butterfingers

02/09/2016

Lipoprotein-nanoplatelets leave researchers hungry to explore drug delivery potential

Business & Regulation Technology and Equipment

The (FD)A-Team

02/09/2016

Are you worried about implementing new manufacturing technology in your plant? Never fear, the FDA’s Emerging Technology Team may be able to lend a helping hand

Discovery & Development Clinical Trials

Clinical Trial Tragedy

02/09/2016

A clinical trial of an FAAH inhibitor in France goes terribly wrong, but whether the compound or manufacturing are to blame remains to be seen

Business & Regulation Business Practice

All Eyes on EMA Approvals

02/09/2016

From anti-cancer viruses to H3 blocking narcolepsy drugs – we present a year in European drug approvals

Discovery & Development Drug Delivery

Three’s a Charm

02/09/2016

Nanoparticles help to deliver a three-in-one attack on metastatic melanoma cells

Business & Regulation Business Practice

The CMO Serialization Threat

02/09/2016

The serialization deadlines are coming. It may seem an age away, but preparing for serialization is not as straightforward as you may think. Do you really want to get left behind?

Business & Regulation Business Practice

The Adverse Event Data Advantage

02/09/2016

A personal experience led us to examine how adverse drug events data can be used to benefit the industry.

Manufacture Technology and Equipment

Layer by Layer

02/09/2016

Does the fabrication of nanoparticles and nanocapules sound complex? Don’t worry – layer by layer technology allows for simple fabrication of complicated stuff.

Manufacture Advanced Medicine

Biopharma's Brave New Biology

02/09/2016

We live in exciting times for the biopharma industry.

Discovery & Development Drug Delivery

Dosing For Compliance

02/09/2016 | Sven Stegemann

Are current dosage forms really as easy and convenient for patients as pharma manufacturers say they are?

Business & Regulation Standards & Regulation

Are You REACH Ready?

02/09/2016

The final deadline for the European Union’s REACH regulation is approaching – and the home stretch will be the most challenging, especially for pharma companies that have failed to recognize their role.

Manufacture Advanced Medicine

A Call for Cell Support

02/09/2016

Engineered cell therapies hold exciting potential for the pharmaceutical industry – but only if contract manufacturing organizations and vendors play their part in the revolution.

Discovery & Development Business Practice

Thinking Inside – and Outside – the Box

02/09/2016

Sitting Down With... Diane Paskiet, Director of Scientific Affairs at West Pharmaceutical Services, USA.

Discovery & Development Drug Delivery

From Brick Dust to Blockbuster?

02/02/2016 | Sponsored by BASF

Many drug candidates are as poorly soluble as “brick dust”, making oral delivery a significant challenge.

Discovery & Development Analytical Science

Ultra-Engineering UHPLC from Scratch

02/09/2016 | Sponsored by Thermo Fisher Scientific

Incremental improvements to ultra-high performance liquid chromatography (UHPLC) have failed to deliver the tangible advances that researchers really want. Sometimes, a full overhaul by re-engineering from the bottom-up is the only way to innovate and move the field forward.

Manufacture Drug Delivery

Aptar Pharma’s Ophthalmic Squeeze Dispenser – Innovation based on experience

02/09/2016 | Sponsored by Aptar

Although the discussion about the use of preservatives is still somewhat controversial, clinical evidence suggests that patients benefit from unpreserved eye drops especially in chronic conditions.

Manufacture Bioprocessing - Single Use Systems

The Rise of Asia’s Biotech Tigers

02/09/2016 | Sponsored by Cytiva

The western world could be considered king of the biotech jungle, but eager biopharma tigers from the east are hungry for a piece of the action – and they are gaining ground. Can single-use technologies help them to catch up even faster? Jinghui Xu believes so.